AgingResearch.NewsJoin free

Microrna delivery

Microrna delivery has been studied in 1 paper since 2026: none in people yet, 1 in cells; 1 in the past year. No study of it in people or animals has been published yet. The newest story, Nov 4, 2026: “RNA delivery boosts responses in aged human T cells in the lab”.

Intervention

1 paper studies it3 findingsUpdated

1 new paper in 30 daysSee all 1 papers on microrna delivery

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Cells and mice: a single group. Worms or flies and humans: nothing yet.

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funders: Division of Engineering Education and Centers and 2 more
  • Cells1

What did studies of microrna delivery find?

3

Studies of microrna delivery measured 3 outcomes; the most studied are T cell activation and cytotoxic responses (1 study), early effector priming (1) and T cell activation and effector function (1).

T cell activation and cytotoxic responses

upin human cells1

1 study

  1. Microrna delivery improves T cell activation and cytotoxic responses in human cells.

    “in aged human CD8+ T cells, multiplexed miRNA enhances activation and cytotoxic responses and sustains an effector-primed state during early activation and expansion.”

    Cellsmultiplexed miRNAsCD8+ T cellduring early activation and expansion

    RNA delivery boosts responses in aged human T cells in the lab

    Cell biomaterials

Early effector priming

upin humans1

1 study

  1. Microrna delivery increases early effector priming in humans following antigen exposure after ex vivo treatment.

    “In vivo, ex vivo-treated aged CD8+ T cells exhibit enhanced early effector priming following antigen exposure.”

    Animalsfollowing antigen exposure after ex vivo treatmentCD8+ T cell

    RNA delivery boosts responses in aged human T cells in the lab

    Cell biomaterials

T cell activation and effector function

upin human cells1

1 study

  1. Microrna delivery improves T cell activation and effector function in human cells.

    “multiplexed miRNA delivery leads to a broader boost in activation responses, effector functions, metabolic health, and cell proliferation.”

    Cellsmultiplexed miRNAsCD8+ T cell

    RNA delivery boosts responses in aged human T cells in the lab

    Cell biomaterials

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months
Cell Biomaterials

RNA delivery boosts responses in aged human T cells in the lab

In laboratory experiments, delivering several gene-regulating RNAs together enhanced activation and cell-killing responses in aged human T cells.In laboratory experiments, delivering several gene-regulating RNAs together enhanced activation and cell-killing responses in aged human T cells.

Human cell studyBlood and immune system
Paper

Related